New cholesterol-lowering drug evolocumab 'halves the risk of a heart attack'

People taking an experimental drug called evolocumab for high cholesterol were half as likely to die or suffer a heart attack or stroke as those taking conventional statins.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news